Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial Of Hematopoietic Stem Cell Transplant (HSCT) For Children With A Genetic Disease Of Blood Cells Without An HLA-Matched Sibling Donor

NCT00730314 is registered in ClinicalTrials.gov with Children's Hospital Los Angeles as lead sponsor.

NCT NCT00730314
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730314 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial Of Hematopoietic Stem Cell Transplant (HSCT) For Children With A Genetic Disease Of Blood Cells Without An HLA-Matched Sibling Donor
Lead sponsor
Children's Hospital Los Angeles
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2008
Completion date
August 31, 2015
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chediak higashi syndrome, fucosidosis, granuloma, hurler disease, neutropenia, niemann-pick disease, osteopetrosis, sickle cell disease, thalassemia, thrombocytopenia, wiskott-aldrich syndrome